About Contraline
Contraline develops male contraceptive solutions, including an investigational drug in the form of a daily topical gel and an investigational implant. These products are designed to provide effective, safe, and reversible contraceptive options for men and couples worldwide. The company operates within the reproductive health and urology space.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Charlottesville, United States
Year Founded
2015
Team Size
11-50
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
contraline.com
Domain Registered Date
Jul 31, 2015
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $92,500,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $10,700,000 · Series-A
Femtech Insider
- Capital Raise
Raised $2,250,000 · Seed
- Milestone
X account created (@contraline)
637 followers
- Milestone
Website domain registered
contraline.com
- Milestone
Company founded
Charlottesville, United States
Investors & Backers
Abstract Ventures
Afton Scientific
Biotechnology Value Fund
Cyan Banister
Founders Fund
Graphene Ventures
GV
Helium-3 Ventures
Invus
Jaffray Woodriff
LAUNCH
Lumira Ventures
MBX Capital
Metaplanet Holdings
RA Capital Management
RH Capital
Rhia Ventures
Shangbay Capital
Smith Ventures
The Syndicate.com
Virginia Venture Partners
Funding History
Series-B+
· Jun 2, 2026
$92,500,000 fundraisingfox.com
Series-A
· Oct 26, 2021
$10,700,000 Femtech Insider
Seed
· Apr 13, 2017
$2,250,000 Source
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026